148 related articles for article (PubMed ID: 29778097)
1. Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.
Johnston AN; Bu W; Hein S; Garcia S; Camacho L; Xue L; Qin L; Nagi C; Hilsenbeck SG; Kapali J; Podsypanina K; Nangia J; Li Y
Breast Cancer Res; 2018 May; 20(1):42. PubMed ID: 29778097
[TBL] [Abstract][Full Text] [Related]
2. Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use.
Taipale H; Solmi M; Correll CU; Tiihonen J
J Clin Psychiatry; 2024 Jan; 85(1):. PubMed ID: 38270548
[No Abstract] [Full Text] [Related]
3. Increasing expectations and knowledge require a more subtle use of prophylactic antipsychotics.
Murray RM; Di Forti M
World Psychiatry; 2018 Jun; 17(2):161-162. PubMed ID: 29856571
[No Abstract] [Full Text] [Related]
4. Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.
Pottegård A; Lash TL; Cronin-Fenton D; Ahern TP; Damkier P
Br J Clin Pharmacol; 2018 Sep; 84(9):2152-2161. PubMed ID: 29858518
[TBL] [Abstract][Full Text] [Related]
5. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.
Shaw V; Srivastava S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():75-83. PubMed ID: 31618686
[TBL] [Abstract][Full Text] [Related]
6. Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments.
Maeshima T; Iijima R; Watanabe M; Yui S; Itagaki F
J Pharm Health Care Sci; 2021 Apr; 7(1):13. PubMed ID: 33789764
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro.
Badran A; Tul-Wahab A; Zafar H; Mohammad N; Imad R; Ashfaq Khan M; Baydoun E; Choudhary MI
PLoS One; 2020; 15(8):e0235676. PubMed ID: 32746451
[TBL] [Abstract][Full Text] [Related]
8. Advances in Immunocompetent Mouse and Rat Models.
Bu W; Li Y
Cold Spring Harb Perspect Med; 2024 Mar; 14(3):. PubMed ID: 37217281
[TBL] [Abstract][Full Text] [Related]
9. Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice.
Bu W; Creighton CJ; Heavener KS; Gutierrez C; Dou Y; Ku AT; Zhang Y; Jiang W; Urrutia J; Jiang W; Yue F; Jia L; Ibrahim AA; Zhang B; Huang S; Li Y
Sci Adv; 2023 May; 9(19):eade0059. PubMed ID: 37172086
[TBL] [Abstract][Full Text] [Related]
10. Identification of target proteins for breast cancer genetic risk loci and blood risk biomarkers in a large study by integrating genomic and proteomic data.
Jia G; Yang Y; Ping J; Xu S; Liu L; Guo X; Tao R; Long J; Zheng W
Int J Cancer; 2023 Jun; 152(11):2314-2320. PubMed ID: 36779764
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic exposure is an independent risk factor for breast cancer: A systematic review of epidemiological evidence.
Gao Z; Xi Y; Shi H; Ni J; Xu W; Zhang K
Front Oncol; 2022; 12():993367. PubMed ID: 36591471
[TBL] [Abstract][Full Text] [Related]
12. Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models.
Ku AT; Young AIJ; Ibrahim AA; Bu W; Jiang W; Lin M; Williams LC; McCue BL; Miles G; Nagi C; Behbod F; Li Y
Cancer Prev Res (Phila); 2023 Feb; 16(2):65-73. PubMed ID: 36343340
[TBL] [Abstract][Full Text] [Related]
13. Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients.
Zhu X; Hu J; Xiao T; Huang S; Shang D; Wen Y
Front Endocrinol (Lausanne); 2022; 13():1011492. PubMed ID: 36313772
[TBL] [Abstract][Full Text] [Related]
14. Effect of serotonin on the cell viability of the bovine mammary alveolar cell-T (MAC-T) cell line.
Dong X; Liu C; Miao J; Lin X; Wang Y; Wang Z; Hou Q
J Anim Sci Technol; 2022 Sep; 64(5):922-936. PubMed ID: 36287778
[TBL] [Abstract][Full Text] [Related]
15. Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics.
Joo SW; Lee BC; Lee J; Seo GH
Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):675-684. PubMed ID: 36263642
[TBL] [Abstract][Full Text] [Related]
16. STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential.
Lin M; Ku AT; Dong J; Yue F; Jiang W; Ibrahim AA; Peng F; Creighton CJ; Nagi C; Gutierrez C; Rosen JM; Zhang XH; Hilsenbeck SG; Chen X; Du YN; Huang S; Shi A; Fan Z; Li Y
Oncogene; 2022 Nov; 41(48):5214-5222. PubMed ID: 36261627
[TBL] [Abstract][Full Text] [Related]
17. Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals.
Leung JCN; Ng DWY; Chu RYK; Chan EWW; Huang L; Lum DH; Chan EWY; Smith DJ; Wong ICK; Lai FTT
Epidemiol Psychiatr Sci; 2022 Sep; 31():e61. PubMed ID: 36059215
[TBL] [Abstract][Full Text] [Related]
18. Prolactin: The Third Hormone in Breast Cancer.
Schuler LA; O'Leary KA
Front Endocrinol (Lausanne); 2022; 13():910978. PubMed ID: 35784527
[TBL] [Abstract][Full Text] [Related]
19. Systematic Analysis of Neurotransmitter Receptors in Human Breast Cancer Reveals a Strong Association With Outcome and Uncovers HTR6 as a Survival-Associated Gene Potentially Regulating the Immune Microenvironment.
Zhang W; Li L; Li J; Yu H; Zheng F; Yan B; Cai W; Chen Y; Yin L; Tang D; Xu Y; Dai Y
Front Immunol; 2022; 13():756928. PubMed ID: 35359970
[TBL] [Abstract][Full Text] [Related]
20. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
